Tumour profile tests offer some hope to cancer patients

Washington

WHEN Jen Morey was diagnosed with colon cancer in June 2013, her oncologist began treating her with a chemotherapy usually prescribed for that type of cancer. But after a couple of months, the malignancy was still growing, and rapidly. The therapy was failing.

So her doctor ordered a test to identify aspects of the tumour's genetic make-up that might be fuelling its growth.